Ruth Isserlin

University Health Network — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index15.1kcitations114works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bioinformatics and Genomic Networks(39), Computational Drug Discovery Methods(22), Gene expression and cancer classification(21), Epigenetics and DNA Methylation(17), Pharmacogenetics and Drug Metabolism(12)

Publications114 total

TMIC-96. Integrated multi-omics reveals distinct hypoxic sub-niches and associated epigenomic and genomic alterations in glioblastoma
Neuro-Oncology·2025Open Access
Abstract B102: A model for the origins of transcriptional heterogeneity in human pancreatic ductal adenocarcinoma
Cancer Research·2025
Gene-set enrichment analysis and visualization on the web using EnrichmentMap:RNASeq
Bioinformatics Advances·2024· 2 citedOpen Access
Supplementary Table 2 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 3 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Data from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 1 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 5 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table Legends from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 1 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Data from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Figures from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 3 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 4 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Methods from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Methods from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Figures from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 2 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table Legends from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
Supplementary Table 4 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Gary D. Bader(33), Andrew Emili(14), Daniele Merico(7), Anthony O. Gramolini(6), Thomas Kislinger(5), Hongbo Guo(5), Alexander R. Pico(4), Véronique Voisin(4), Shraddha Pai(4), Vincent Fong(4), Neil Fleshner(4), Bharati Bapat(4), A.M. Edwards(3), Eric R. Lechman(3), Erwin M. Schoof(3), Stephanie M. Dobson(3), Aaron C. Trotman-Grant(3), Gabriela Krivdova(3), Karin G. Hermans(3), Peter W. Zandstra(3)